Applicant, as named in the Orange Book

Bioxcel

Next listed expiry: Igalmi on 12 Jan 2043. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Igalmi · 2 strengths dexmedetomidine hydrochloride	dexmedetomidine hydrochloride	215390	12 Jan 2043	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.